Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes

This study aimed to investigate the effects of fluconazole, a moderate inhibitor of CYP2C9 and CYP3A4, on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes. A total of thirty-nine healthy Korean male volunteers were divided into three different CYP2C9...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of pharmacal research Jg. 48; H. 3; S. 224 - 233
Hauptverfasser:	Cho, Chang-Keun, Kang, Pureum, Jang, Choon-Gon, Lee, Yun Jeong, Bae, Jung-Woo, Choi, Chang-Ik, Lee, Seok-Yong
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Seoul Pharmaceutical Society of Korea 01.03.2025 대한약학회
Schlagworte:	Administration, Oral Adult Antifungal Agents - administration & dosage Antifungal Agents - pharmacology carboxylic acids Carboxylic Acids - metabolism Carboxylic Acids - pharmacokinetics Celecoxib - administration & dosage Celecoxib - blood Celecoxib - pharmacokinetics Cyclooxygenase 2 Inhibitors - administration & dosage Cyclooxygenase 2 Inhibitors - pharmacokinetics Cytochrome P-450 CYP2C9 - genetics Cytochrome P-450 CYP2C9 - metabolism Drug Interactions fluconazole Fluconazole - administration & dosage Fluconazole - pharmacology Genotype Healthy Volunteers Humans Male males Medicine metabolites oral administration pharmacokinetics Pharmacology/Toxicology Pharmacy Research Article Young Adult 약학 CYP2C9 Genotype Celecoxib Fluconazole Pharmacokinetics Celecoxib carboxylic acid
ISSN:	0253-6269, 1976-3786, 1976-3786
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!